Erythromycin 333 MG Delayed Release Oral Tablet [Ery-Tab]

Known as: ERY-TAB 333 MG Delayed Release Oral Tablet, Erythromycin 333 mg ORAL TABLET, DELAYED RELEASE [ERY-TAB] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
To the editor: We read with great interest the recently published article by Choi et al., which de scri bes the first reported… (More)
Is this relevant?
2014
2014
Chromomycosis or chromoblastomycosis is a chronic deep skin mycosis that affects the skin and subcutaneous tissue and is caused… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 1
Is this relevant?
2014
2014
Studies to ascertain levels of erythrocyte glutathione S-transferase (EryGST) activity of non-malarious and malarious male… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
Th The e e Ce Ce Cent nt nter er er f f for or C C Cor or ron on onar ary y y Ar A A te te ery ry ry A A An no noma ma mali li… (More)
Is this relevant?
2011
2011
A variety of antibiotics and their metabolites at sub-inhibitory level concentrations are suspected to expand resistance genes in… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2006
2006
OBJECTIVES To test whether smeDEF overexpression leads to a predictable multi-drug resistance phenotype in Stenotrophomonas… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2005
2005
More than a syndrome, Lyme disease (Lyme borreliosis) is a specific tickborne zoonosis caused in North America by infection with… (More)
Is this relevant?
1994
1994
Dr. G. Fernández Zataraín, Servicio de Nefrología, Hospital General de Castellón, Avenida de Benicasim, s/n, E-12004 Castellón… (More)
Is this relevant?